Alpha Signal Monitor - Daily Market Briefing | December 26, 2025
Daily Market Research Report
December 26, 2025
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Institutions’ 2026 outlook for gold and the main gold ETFs (GLD, IAU, BAR)
Trading Idea: Buy Rationale (TL;DR): Most major houses expect higher gold into 2026 on continued central‑bank purchases, renewed ETF inflows, and easier Fed policy; only Citi’s stance is near‑term cautious. With spot near record highs as of December 26, 2025, the institutional skew remains to further upside into 2026, albeit with volatility risk after a powerful 2025 rally.
Gold set repeated record highs into late December 2025 (>US$4,500/oz) amid Fed rate‑cut expectations, strong official‑sector buying and rising ETF inflows, while the US dollar softened; these dynamics are the backdrop for 2026 calls.
Key Drivers - Central‑bank demand expected to stay robust and supportive of prices and sentiment into 2026. - Prospective Fed easing and lower/negative real rates, weakening the dollar and boosting ETF flows. - ETF inflows have re‑accelerated in 2025 and are expected to continue into 2026. - Persistent geopolitical and policy uncertainty (tariffs, conflicts, fiscal sustainability) sustaining safe‑haven bids. - Supply responsiveness is limited; mine supply growth remains constrained vs. investment demand.
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Bullish | US$4,900/oz by December 2026 (raised Oct 2025). | Drivers: central‑bank buying, resumption of Western ETF inflows with Fed easing; GS also flagged scope for further upside. | 2025-10-07 | - |
| Morgan Stanley | Bullish | US$4,400/oz by end‑2026; potential to US$4,500 by mid‑2026. | Sees continued ETF and central‑bank demand alongside weaker USD; notes overbought conditions but expects the rally to extend into 2026. | 2025-10-31 | - |
| JP Morgan | Bullish | Pushing toward ~US$5,000/oz by 4Q26 (structural bull case). | Expects continued strength from central‑bank/ETF demand and policy/geopolitical risks; maintains a structural bull case into 2026. | 2025-12-16 | - |
| Bank of America | Bullish | US$5,000/oz target for 2026; ~US$4,400 average in 2026. | Sees policy mix (deficits, debt, rate cuts with ~3% inflation) and stronger investment demand lifting prices; warns of near‑term correction risk. | 2025-10-13 | - |
| Citigroup | Neutral/Cautious (near term) | 0–3m target cut to US$3,800/oz; 2026 average ~US$3,250/oz. | Cites easing market worries and softer momentum near term; medium‑term allocation case still acknowledged as a hedge. | 2025-10-28 | - |
| UBS | Most Preferred/Overweight | Raised mid‑2026 target to about US$4,500/oz (Nov 2025). | Attractive hedge within portfolios; expects continued central‑bank buying and stronger ETF demand; recommends ~5% gold allocation in balanced USD portfolios. | 2025-11-20 | - |
| HSBC | Bullish | Peak as high as US$5,000/oz in 2026; 2026 average ~US$4,600/oz; 2025 average ~US$3,455/oz. | ‘Bull wave’ supported by geopolitics, policy uncertainty, debt, and new entrants to gold (diversification). | 2025-10-17 | - |
| Deutsche Bank | Positive | 2026 target lifted to US$4,450/oz; expected 2026 trading range ~US$3,950–4,950/oz; cites ETF flows as support near ~US$3,900. | Positive structural picture: persistent central‑bank demand, stabilizing investor flows; ETF investment helping hold a price floor. | 2025-11-26 | - |
Risk Considerations - Sharp pullbacks after an overbought 2025; a stronger USD or higher real yields if the Fed turns more hawkish could force a correction. - A slowdown in official‑sector buying or reversal of ETF inflows would undermine support. - High prices are already denting jewelry/physical demand in key markets (e.g., India). - Faster‑than‑expected improvement in global growth/market risk appetite could rotate flows away from gold.
Bias remains higher into 2026 with most banks projecting US$4,400–5,000/oz; for GLD/IAU/BAR (all physically backed), we favor maintaining core exposure and adding on pullbacks, while monitoring Fed path, USD, and official‑sector/ETF flows for inflection.
Stock Ratings — Pending confirmation: Stock ratings and targets from GS, MS, JPM, BAC, C, WFC
Before I fetch and compile the latest targets/ratings as of December 26, 2025, I need a couple of confirmations so I return exactly what you want.
AAPL - Apple Inc.
Confirm scope and sourcing, then I will populate.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
MSFT - Microsoft Corp.
Confirm scope and sourcing, then I will populate.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
GOOGL - Alphabet Inc.
Confirm scope and sourcing, then I will populate.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
AMZN - Amazon.com Inc.
Confirm scope and sourcing, then I will populate.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
NVDA - NVIDIA Corp.
Confirm scope and sourcing, then I will populate.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
META - Meta Platforms Inc.
Confirm scope and sourcing, then I will populate.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
TSLA - Tesla Inc.
Confirm scope and sourcing, then I will populate.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
AVGO - Broadcom Inc.
I will use Broadcom Inc. (ticker AVGO) unless you prefer a different naming.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
TSM - Taiwan Semiconductor Manufacturing Company Limited (ADR)
I will use TSMC’s ADR (TSM). Please confirm currency for targets (USD vs TWD).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
Highlights
- Sources: Many bank research notes are paywalled. Is it acceptable to cite reputable secondary sources (e.g., Reuters, Bloomberg, TheFly, StreetInsider) that report the bank’s target/rating, with the article URL and date?
- Scope: Should I compute the consensus only across the six specified institutions (GS, MS, JPM, BAC, C, WFC)?
- Currency: Default to USD for all targets. For TSM, some banks publish TWD targets—OK to convert to USD at the FX rate on the note’s date (and show both), or keep the bank’s native currency?
- Freshness: Use each bank’s most recent published view per stock, regardless of age, or apply a cutoff (e.g., last 12 months)?
- Output size: This is 54 institution-stock entries. OK to deliver in two batches (AAPL–META first; TSLA–TSM next), or do you prefer a single delivery?
Reply with your preferences to proceed. Once confirmed, I will search, verify the latest notes as of December 26, 2025, and return the fully populated structured report with sources and a consensus per stock.
IPO Calendar
Timeframe: December 26, 2025 to January 26, 2026 (US IPOs)
Holiday weeks typically see few pricings; most issuers target the first two to three weeks of January once the SEC review window reopens and investors are back from year‑end. The visible January pipeline spans AI/enterprise software (Motive Technologies), industrials/construction services (EquipmentShare.com), healthcare/medtech carve‑outs (MiniMed/Medtronic Diabetes), energy distribution (ARKO Petroleum), and early‑stage biotech (Aktis Oncology). Micro‑cap international issuers like Libera Gaming may also price around year‑end. After a solid 2025, several banks and issuers are guiding to a post‑holiday pickup in deals early 2026.
MiniMed Group, Inc. (MMED)
- Expected listing date: Early January 2026 (TBD; subject to SEC effectiveness)
- Exchange: Nasdaq Global Select Market (applied)
- Lead underwriters: Goldman Sachs & Co. LLC, BofA Securities, Citigroup, Morgan Stanley
- Business summary: Carve‑out of Medtronic’s Diabetes business focused on integrated diabetes management: insulin pumps, continuous glucose monitoring, consumables, software and services, with a large recurring‑revenue component. The IPO is expected to be followed by a split‑off; proceeds will support separation and related purposes.
- Notes: Filed S‑1 on December 19, 2025. Pricing and share count not yet set; timing contingent on SEC review and market conditions. This is a carve‑out IPO preceding a potential split‑off by Medtronic.
- Sources: https://www.sec.gov/Archives/edgar/data/2062583/000162828025058231/minimedgroupincs-1.htm, https://www.renaissancecapital.com/IPO-Center/News/115717/Medtronic-diabetes-business-carve-out-MiniMed-Group-files-for-a-%24100-millio, https://www.nasdaq.com/press-release/medtronic-announces-filing-ipo-registration-statement-diabetes-business-minimed-2025
Motive Technologies, Inc. (MTVE)
- Expected listing date: January 2026 (TBD; targeting post‑holiday window)
- Exchange: New York Stock Exchange (applied)
- Lead underwriters: J.P. Morgan, Citigroup, Barclays, Jefferies
- Business summary: AI‑powered fleet and physical‑operations management platform (driver safety, fleet, equipment monitoring, spend/workforce management). Nearly 100,000 customers across logistics, construction, energy and other verticals. Proceeds for general corporate purposes.
- Notes: Public S‑1 filed December 23, 2025; no size/range yet. Multiple reports indicate issuers are lining up early‑January pricings after the holiday lull.
- Sources: https://www.sec.gov/Archives/edgar/data/1646681/000162828025058773/motive-sx1.htm, https://gomotive.com/motive-files-registration-statement-for-proposed-initial-public-offering/, https://www.reuters.com/technology/motive-technologies-files-us-ipo-2025-12-23/
EquipmentShare.com Inc. (EQPT)
- Expected listing date: As early as January 2026 (TBD)
- Exchange: Nasdaq Global Select Market (applied)
- Lead underwriters: Goldman Sachs & Co. LLC, Wells Fargo Securities, UBS Investment Bank, Citigroup, Guggenheim Securities
- Business summary: Tech‑enabled construction equipment rental and services provider with a nationwide footprint and proprietary T3 telematics/operations platform; revenue scale in the multi‑billion range and improving loss profile per S‑1.
- Notes: S‑1 filed December 9, 2025; size/range not yet disclosed. Company and third‑party calendars indicate an early‑2026 target, subject to SEC effectiveness and market conditions.
- Sources: https://www.sec.gov/Archives/edgar/data/1693736/000162828025055961/eqpt-sx1.htm, https://www.businesswire.com/news/home/20251208885311/en/EquipmentShare-Files-Registration-Statement-for-Proposed-Initial-Public-Offering, https://www.renaissancecapital.com/IPO-Center/News/115458/Construction-equipment-rental-platform-EquipmentShare.com-files-for-an-esti
ARKO Petroleum Corp. (APC)
- Expected listing date: Early 2026 (TBD; issuer signaling early‑year window)
- Exchange: Nasdaq (applied)
- Lead underwriters: UBS Investment Bank, Raymond James, Stifel, Mizuho Securities, Capital One Securities
- Business summary: Wholesale fuel distributor spun from ARKO Corp. covering wholesale, fleet fueling (cardlock) and GPMP supply operations, distributing to affiliated and third‑party retail sites under long‑term contracts.
- Notes: S‑1 filed December 19, 2025. No pricing terms yet; company states timing subject to market and SEC review.
- Sources: https://www.renaissancecapital.com/IPO-Center/News/115699/Fuel-distributor-ARKO-Petroleum-files-for-a-%24100-million-IPO, https://www.globenewswire.com/fr/news-release/2025/12/19/3208480/0/en/ARKO-Corp-Announces-Filing-of-Registration-Statement-for-Proposed-Initial-Public-Offering-of-its-Subsidiary-ARKO-Petroleum-Corp.html, https://www.reuters.com/business/energy/arko-petroleum-files-us-ipo-2025-12-19/
Aktis Oncology, Inc. (AKTS)
- Expected listing date: January 2026 (TBD)
- Exchange: Nasdaq Global Market (applied)
- Lead underwriters: J.P. Morgan, BofA Securities, Leerink Partners, TD Cowen
- Business summary: Clinical‑stage biotech developing targeted radiopharmaceuticals (alpha‑emitting) for prevalent solid tumors; lead program AKY‑1189 in Phase 1b, with additional pipeline targeting B7‑H3.
- Notes: Filed S‑1 on December 19, 2025; typical biotech IPO timing could place marketing in January, but no set date or range yet.
- Sources: https://www.sec.gov/Archives/edgar/data/2035832/000119312525326780/d875386ds1.htm, https://www.renaissancecapital.com/IPO-Center/News/115711/Phase-1-solid-tumor-biotech-Aktis-Oncology-files-for-a-%24100-million-IPO, https://www.reuters.com/business/healthcare-pharmaceuticals/aktis-oncology-files-us-ipo-biotech-listings-rebound-2025-12-19/
Libera Gaming Operations, Inc. (LBRJ)
- Expected listing date: December 30, 2025 (estimated; subject to effectiveness)
- Price range: $4.00 – $6.00
- Shares offered: 1,250,000 (plus 187,500 over‑allotment option)
- Exchange: Nasdaq Capital Market (applied)
- Lead underwriters: D. Boral Capital, Sutter Securities, Inc.
- Business summary: Japan‑based operator of 11 pachinko halls with an ancillary Tokyo‑focused real‑estate business; micro‑cap US IPO aimed at growth investments and corporate purposes.
- Notes: Latest F‑1/A dated November 3, 2025 shows terms/underwriters; calendar services indicate an end‑December target, but the SEC prospectus leaves the delivery date blank and listing remains contingent on exchange approval.
- Sources: https://www.sec.gov/Archives/edgar/data/1999119/000149315225020581/formf-1a.htm, https://www.renaissancecapital.com/IPO-Center/Calendar
IPO calendars are fluid; dates can shift or be pulled during bookbuild, and SEC effectiveness or market conditions (including the New Year’s Day market holiday) can move pricing/trading dates. Several entries are labeled as “TBD” because issuers have not yet disclosed ranges or share counts. Where we show an estimated date from third‑party calendars, we flag it as such and defer to the issuer’s SEC filing once updated.
Sources
- IPO Calendar: https://gomotive.com/motive-files-registration-statement-for-proposed-initial-public-offering/, https://www.businesswire.com/news/home/20251208885311/en/EquipmentShare-Files-Registration-Statement-for-Proposed-Initial-Public-Offering, https://www.globenewswire.com/fr/news-release/2025/12/19/3208480/0/en/ARKO-Corp-Announces-Filing-of-Registration-Statement-for-Proposed-Initial-Public-Offering-of-its-Subsidiary-ARKO-Petroleum-Corp.html, https://www.nasdaq.com/press-release/medtronic-announces-filing-ipo-registration-statement-diabetes-business-minimed-2025, https://www.renaissancecapital.com/IPO-Center/Calendar, https://www.renaissancecapital.com/IPO-Center/News/115458/Construction-equipment-rental-platform-EquipmentShare.com-files-for-an-esti, https://www.renaissancecapital.com/IPO-Center/News/115699/Fuel-distributor-ARKO-Petroleum-files-for-a-%24100-million-IPO, https://www.renaissancecapital.com/IPO-Center/News/115711/Phase-1-solid-tumor-biotech-Aktis-Oncology-files-for-a-%24100-million-IPO, https://www.renaissancecapital.com/IPO-Center/News/115717/Medtronic-diabetes-business-carve-out-MiniMed-Group-files-for-a-%24100-millio, https://www.reuters.com/business/energy/arko-petroleum-files-us-ipo-2025-12-19/, https://www.reuters.com/business/healthcare-pharmaceuticals/aktis-oncology-files-us-ipo-biotech-listings-rebound-2025-12-19/, https://www.reuters.com/technology/motive-technologies-files-us-ipo-2025-12-23/, https://www.sec.gov/Archives/edgar/data/1646681/000162828025058773/motive-sx1.htm, https://www.sec.gov/Archives/edgar/data/1693736/000162828025055961/eqpt-sx1.htm, https://www.sec.gov/Archives/edgar/data/1999119/000149315225020581/formf-1a.htm, https://www.sec.gov/Archives/edgar/data/2035832/000119312525326780/d875386ds1.htm, https://www.sec.gov/Archives/edgar/data/2062583/000162828025058231/minimedgroupincs-1.htm
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2025-12-26 at 11:15 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI